The anandamide transport inhibitor AM404 activates vanilloid receptors
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The possibility that the anandamide transport inhibitor N-(4-hydroxyphenyl)-5,8,11,14-eicosatetraenamide (AM404), structurally similar to the vanilloid receptor agonists anandamide and capsaicin, may also activate vanilloid receptors and cause vasodilation was examined. AM404 evoked concentration-dependent relaxations in segments of rat isolated hepatic artery contracted with phenylephrine. Relaxations were abolished in preparations pre-treated with capsaicin. The calcitonin-gene related peptide (CGRP) receptor antagonist CGRP-(8-37) also abolished relaxations. The vanilloid receptor antagonist capsazepine inhibited vasodilation by AM404 and blocked AM404-induced currents in patch-clamp experiments on Xenopus oocytes expressing the vanilloid subtype 1 receptor (VR1). In conclusion, AM404 activates native and cloned vanilloid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“N-arachidonoylphenolamine is an agonist at TRPV1 receptors and an inhibitor of cellular anandamide uptake, which leads to increased levels of endogenous cannabinoids”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [235]
In the citing paper
“a direct action of AM404 on cannabinoid CB 1 receptors seems negligible, as suggested by its quite low affinity (K i values for CB 1 receptors are 78 nM for anandamide and 1760 nM for AM404) (235), and also by the fact that AM404, in contrast to cannabinoid CB 1 receptor agonists, does not inhibit forskolininduced cyclic AMP accumulation (19).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [235]
In the citing paper
“At this concentration AM404 activates both rat (102,235) and human (66) TRPV1 receptors, while significant COX-1 and COX-2 inhibition and prostaglandin E 2 formation reduction are obtained at micromolar concentrations (102).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [235]
In the citing paper
“At analgesic doses of paracetamol, AM404 that is formed in rat brain regions expressing high levels of FAAH, can indirectly activate CB 1 receptors and directly activate TRPV1 receptors (66,102,235).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [235]
In the citing paper
“In Zygmunt et al’s patch-clamp experiment, AM404 activated the vanilloid receptor TRPV1, an effect that was suppressed after administration of the TRPV1 antagonist, capsazepine.49”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The capsaicin receptor: a heat-activated ion channel in the pain pathway
Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. (1997) · Nature · doi:10.1038/39807 · Cited by 9,107
Self-citationVanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Self-citationPharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin
Bevan, S., Hothi, S., Hughes, G., James, I. F., Rang, H. P., Shah, K., Walpole, C. S. J., & Yeats, J. C. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb12781.x · Cited by 587
Melck, D., Bisogno, T., De Petrocellis, L., Chuang, H.-H., Julius, D., Bifulco, M., & Di Marzo, V. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1105 · Cited by 188
Self-citationHead Group Analogs of Arachidonylethanolamide, the Endogenous Cannabinoid Ligand
Khanolkar, A. D., Abadji, V., Lin, S., Hill, W. A. G., Taha, G., Abouzid, K., Meng, Z., Fan, P., & Makriyannis, A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960152y · Cited by 158
Interactions between synthetic vanilloids and the endogenous cannabinoid system
Di Marzo, V., Bisogno, T., Melck, D., Ross, R., Brockie, H., Stevenson, L., Pertwee, R., & De Petrocellis, L. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01175-2 · Cited by 158
Potentiation of anandamide hypotension by the transport inhibitor, AM404
Calignano, A., La Rana, G., Beltramo, M., Makriyannis, A., & Piomelli, D. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01297-1 · Cited by 96
Pertwee, R. G. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00282-9 · Cited by 84
Cited by
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
“AM404 is another anandamide analog that activates vanilloid receptors (Jerman et al., 2000; Zygmunt et al., 2000; Ross et al., 2001), albeit at concentrations no higher than those at which it inhibits anandamide membrane transport (Beltramo et al., 1997; Piomelli et al., 1999).”
BackgroundThe Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“Interestingly, direct agonists of CB1 receptors, such as CP55,940, only produced a very modest effect compared with the anandamide transport inhibitor AM404, which also exhibits affinity for the VR1 receptor (Zygmunt et al., 2000).”
BackgroundThe Vanilloid Receptor: A Molecular Gateway to the Pain Pathway
Caterina, M. J., & Julius, D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.487 · Cited by 1,575
Self-citationDrugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Targeting the endocannabinoid system: to enhance or reduce?
Di Marzo, V. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798
Metadata
- Authors
- Zygmunt, P. M., Chuang, H.-H., Movahed, P., Julius, D., & Högestätt, E. D.
- Affiliations
- Lund University (SE)
- University of California, San Francisco (US)
- Corresponding author
- Zygmunt, Peter M
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2000-05
- Volume
- 396
- Issue
- 1
- Pages
- 39-42
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W1981876620
- Cited by
- 270
- References
- 13
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 9 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 10 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 4 · 2015: 10 · 2014: 11 · 2013: 4 · 2012: 9
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- European Journal of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Keywords
- AM404, TRPV1, vasodilation, capsaicin, calcitonin gene-related peptide, capsazepine
- MeSH terms
- Rimonabant, Animals, Arachidonic Acids, Cannabinoids, Capsaicin, Female, Hepatic Artery, Muscle Contraction, Muscle, Smooth, Vascular, Oocytes, Peptide Fragments, Piperidines, Pyrazoles, Receptors, Drug, Vasodilation, Xenopus, Calcitonin Gene-Related Peptide, Rats, Wistar, Patch-Clamp Techniques, Rats, Polyunsaturated Alkamides, Endocannabinoids, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The anandamide transport inhibitor AM404 activates vanilloid receptors. https://app.cochat.ai/papers/10.1016/s0014-2999(00)00207-7
- The paper
- Zygmunt, P. M., Chuang, H.-H., Movahed, P., Julius, D., & Högestätt, E. D. (2000). The anandamide transport inhibitor AM404 activates vanilloid receptors. European Journal of Pharmacology. https://doi.org/10.1016/s0014-2999(00)00207-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.